ARTICLE
28 February 2022

Some U.S.-Listed Chinese Stocks Will Need Beijing's Approval To Stay Public In Other Overseas Markets

MF
Morrison & Foerster LLP

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
Morrison & Foerster partner and global chair of the Private Equity Group Marcia Ellis is quoted in an article, "Some U.S.-listed Chinese stocks will need...
Worldwide Corporate/Commercial Law

Morrison & Foerster partner and global chair of the Private Equity Group Marcia Ellis is quoted in an article, "Some U.S.-listed Chinese stocks will need Beijing's approval to stay public in other overseas markets" published by CNBC  on February 19, 2022.

In the article, Marcia suggested that U.S.-listed, China-based companies that pursue secondary or dual listings in Hong Kong only need the CAC's review if the regulator identifies a national security risk related to the companies' products or data processing. She also mentioned that's "a different threshold" from the CAC review required for listings outside of China in markets such as London or Singapore. 

Read the full article.

Originally published by CNBC

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More